How does menopause change skin?

Menopause causes a sustained decline in circulating oestrogen, which directly reduces fibroblast activity throughout the dermis. The result is a fall in collagen synthesis — estimated at approximately 30 per cent of dermal collagen in the first five years post-menopause — alongside reduced elastin production, diminished glycosaminoglycan content and impaired barrier function. Clinically, this manifests as progressive skin thinning, volume deflation in the mid-face, deepening rhytids, increased fragility and a loss of structural support along the jawline and neck. These changes require interventions that address the collagen deficit directly, not simply hydrate the surface.

Best treatments for perimenopause?

For perimenopausal skin, the priority is addressing early collagen depletion before structural loss becomes pronounced. Poly-L-lactic acid biostimulators (Sculptra) are the most evidence-supported option for rebuilding the collagen scaffold, and are often combined with hyperdiluted calcium hydroxyapatite (Radiesse) for concurrent structural support. Radiofrequency microneedling (Morpheus8) addresses dermal thinning and texture changes. HIFU with Ultraformer MPT is added when early laxity at the SMAS level becomes apparent. Regenerative adjuncts such as PDRN support hydration between primary sessions.

Hormonal therapy + aesthetics?

Menopausal hormone therapy and aesthetic treatment operate through different mechanisms and complement each other. HRT partially restores systemic oestrogen signalling, which can improve fibroblast function, skin hydration and thickness. However, HRT does not fully reverse accumulated collagen loss, does not address SMAS laxity, and does not correct regional volume depletion or pigmentary changes. Aesthetic biostimulation and energy-based treatments target these deficits locally and structurally. Patients combining both approaches tend to respond well to collagen biostimulators. Any change in hormonal therapy should be communicated to the treating physician.

Cost of annual protocol?

The cost of a full annual protocol varies considerably depending on which modalities are required, the number of sessions indicated, and the products used. A comprehensive protocol combining Sculptra, Morpheus8, Ultraformer MPT and regenerative adjuncts over twelve months represents a substantial investment. At this clinic, a precise cost is discussed during the initial consultation, once the individualised protocol is designed based on clinical assessment. The protocol is best approached as a multi-year maintenance commitment rather than a single-course procedure.

Collagen biostimulation operates on a biological timeline that cannot be accelerated. After a Sculptra session, the PLLA microparticles stimulate fibroblast activity progressively over sixty to ninety days — visible improvement builds over three to four months per session, not immediately. A full primary protocol spanning two to three sessions, combined with energy-based modalities, typically takes six to twelve months to deliver its full clinical result. Patients who understand this timeline from the outset tend to have the most satisfying outcomes, as they track cumulative improvement rather than expecting immediate visible change after a single session.

Facial biostimulators

Menopausal skin: aesthetic protocol for women in Brasília

A clinically structured, multi-modal approach to the skin changes of perimenopause and menopause — addressing collagen loss, laxity and dermal thinning with precision sequencing.

Book Consultation

How oestrogen decline restructures the skin

Menopause does not simply dry the skin — it systematically dismantles the structural proteins that give it thickness, resilience and contour. The mechanism is hormonal: oestrogen receptors are expressed throughout the dermis, epidermis and dermal fibroblasts. When circulating oestrogen falls during perimenopause and ceases in menopause, fibroblast activity declines and the synthesis of both type I and type III collagen slows markedly. Peer-reviewed data from Thornton (Ageing Research Reviews, 2013) quantify this loss at approximately 30 per cent of dermal collagen in the first five years after menopause alone — a rate substantially faster than chronological ageing.

The consequences are multi-layered. The dermis thins progressively, reducing the structural scaffold that supports overlying tissue. Glycosaminoglycan production — including hyaluronic acid — falls, diminishing the skin's intrinsic capacity for water retention. Elastin fibres degrade without adequate replacement, accelerating laxity at the jawline, neck and periorbital regions. Barrier function deteriorates, increasing transepidermal water loss and susceptibility to irritation.

Clinically, these changes present as: progressive fine to deep rhytids across the face, accelerated volume deflation in the mid-face and temples, jowl formation along the mandibular border, and a characteristic thinned, crepe-like texture. Rosacea can flare in perimenopause due to altered vascular reactivity. Melasma frequently intensifies during hormonal fluctuation. Each of these manifestations has a distinct anatomical substrate, and each responds differently to available aesthetic modalities.

Ask a question on WhatsApp →

Recommended treatments for menopausal skin: a sequenced approach

Effective management of menopausal skin changes requires layered interventions targeting different tissue planes simultaneously. The following modalities are prioritised based on their mechanism of action relative to oestrogen-mediated structural loss:

Sculptra (poly-L-lactic acid biostimulator) — first priority for collagen scaffold rebuilding. Sculptra stimulates fibroblast-mediated neocollagenesis over sixty to ninety days per session. In the context of the hormonal collagen deficit, PLLA biostimulation is the most direct pharmacological response available. A standard protocol involves two to three sessions at six-week intervals.
Radiesse hyperdiluted (calcium hydroxyapatite) — second priority for immediate structural support and concurrent biostimulation. Hyperdiluted CaHA provides immediate mechanical scaffolding while simultaneously stimulating collagen and elastin production. Particularly indicated for the lower face, neck and décolletage.
Ultraformer MPT (HIFU) — for SMAS-level tightening and lifting. High-intensity focused ultrasound targets the superficial musculoaponeurotic system at depths unreachable by injectables, addressing ptosis and mandibular border definition. Typically positioned six to eight weeks after the first biostimulator session.
Morpheus8 (fractional radiofrequency microneedling) — for dermal remodelling and texture. RF energy delivered into the dermis stimulates collagen contraction and remodelling, addressing thinning, pore size and texture.
PRP or PDRN (regenerative adjuncts) — for hydration, vascularity and recovery support. Platelet-rich plasma and polynucleotides (PDRN) provide growth factor signalling and hydration scaffolding between biostimulator sessions.

HRT, annual protocol structure and cost context

A question raised consistently in consultations with patients undergoing menopausal hormone therapy (MHT or HRT) is whether systemic hormones reduce the need for aesthetic intervention. The evidence-based answer is: HRT is complementary, not substitutive. Oestrogen therapy does partially restore fibroblast activity and improves skin hydration and thickness — particularly when initiated within the first years of menopause. Patients on adequate HRT typically present with somewhat less severe structural collagen loss than those without, and often respond more vigorously to biostimulation.

However, HRT does not fully reverse the cumulative collagen deficit that has already occurred, does not address acquired laxity at the SMAS level, and does not correct pigmentary changes or dermal thinning in periorbital and mandibular regions. Aesthetic intervention therefore adds to what HRT achieves systemically — and the two are best coordinated, not positioned as alternatives.

A representative annual protocol for a perimenopausal or postmenopausal patient at this clinic follows a sequenced rhythm: Sculptra session one (month one), Morpheus8 (month two), Sculptra session two (month three), Ultraformer MPT (month four to five), PDRN adjunct session (month six), clinical review and reassessment (month nine). This is an illustrative sequence — the actual protocol is individualised at consultation based on baseline assessment, hormonal status and treatment response.

Regarding cost: a full annual protocol of this scope involves multiple sessions across several modalities. An honest cost context is provided during consultation once the individual protocol is designed — rather than quoting a bundled figure that may not reflect what a specific patient requires. The investment is best understood as a multi-year maintenance commitment.

All information on this page was last reviewed by Dr. Thiago Perfeito, CRM-DF 23199, on 21 June 2026.

Dr. Thiago Perfeito

CRM-DF 23199 · Aesthetic and Regenerative Medicine

Physician with more than 10 years of practice in aesthetic and regenerative medicine. Master's degree in Aesthetic Medicine (2024). International training at Harvard Medical School and Mayo Clinic. Member of ASLMS, A4M, AMS, and NYAS. Practicing in Brasília, Lago Sul.

Learn about Dr. Thiago →

Frequently asked questions about Menopause skin protocol

How does menopause change skin?

Menopause causes a sustained decline in circulating oestrogen, which directly reduces fibroblast activity throughout the dermis. The result is a fall in collagen synthesis — estimated at approximately 30 per cent of dermal collagen in the first five years post-menopause — alongside reduced elastin production, diminished glycosaminoglycan content and impaired barrier function. Clinically, this manifests as progressive skin thinning, volume deflation in the mid-face, deepening rhytids, increased fragility and a loss of structural support along the jawline and neck. These changes require interventions that address the collagen deficit directly, not simply hydrate the surface.
Best treatments for perimenopause?

For perimenopausal skin, the priority is addressing early collagen depletion before structural loss becomes pronounced. Poly-L-lactic acid biostimulators (Sculptra) are the most evidence-supported option for rebuilding the collagen scaffold, and are often combined with hyperdiluted calcium hydroxyapatite (Radiesse) for concurrent structural support. Radiofrequency microneedling (Morpheus8) addresses dermal thinning and texture changes. HIFU with Ultraformer MPT is added when early laxity at the SMAS level becomes apparent. Regenerative adjuncts such as PDRN support hydration between primary sessions.
Hormonal therapy + aesthetics?

Menopausal hormone therapy and aesthetic treatment operate through different mechanisms and complement each other. HRT partially restores systemic oestrogen signalling, which can improve fibroblast function, skin hydration and thickness. However, HRT does not fully reverse accumulated collagen loss, does not address SMAS laxity, and does not correct regional volume depletion or pigmentary changes. Aesthetic biostimulation and energy-based treatments target these deficits locally and structurally. Patients combining both approaches tend to respond well to collagen biostimulators. Any change in hormonal therapy should be communicated to the treating physician.
Cost of annual protocol?

The cost of a full annual protocol varies considerably depending on which modalities are required, the number of sessions indicated, and the products used. A comprehensive protocol combining Sculptra, Morpheus8, Ultraformer MPT and regenerative adjuncts over twelve months represents a substantial investment. At this clinic, a precise cost is discussed during the initial consultation, once the individualised protocol is designed based on clinical assessment. The protocol is best approached as a multi-year maintenance commitment rather than a single-course procedure.
Realistic timeline?

Collagen biostimulation operates on a biological timeline that cannot be accelerated. After a Sculptra session, the PLLA microparticles stimulate fibroblast activity progressively over sixty to ninety days — visible improvement builds over three to four months per session, not immediately. A full primary protocol spanning two to three sessions, combined with energy-based modalities, typically takes six to twelve months to deliver its full clinical result. Patients who understand this timeline from the outset tend to have the most satisfying outcomes, as they track cumulative improvement rather than expecting immediate visible change after a single session.

Schedule a menopausal skin consultation in Brasília

Dr. Thiago Perfeito, CRM-DF 23199, sees patients at INTI clinic, Lago Sul. The initial consultation includes a full skin assessment, hormonal context review and individualised protocol design. Contact via WhatsApp to arrange an appointment.

Book on WhatsApp Browse all procedures